Shots: The BTD is based on P-II WILLOW study assessing brensocatib vs PBO in adults with NCFBE for reducing exacerbations Insmed expects to initiate a P-III program for brensocatib in […]readmore
Tags : Non-Cystic Fibrosis Bronchiectasis